💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Mirati Therapeutics, Inc. (MRTX)
« Back to company indexMRTX Chatter Timeline
Stock Ticker for MRTX
Most Active Tweeters for MRTX
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @bearcapital1 | 3 |
| @optstrader1 | 3 |
| @QuantchaIdeas | 3 |
| @biotechinvstr | 3 |
Recent Tweets for MRTX
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in MIRATI THERAPEUTICS INC. COMM $MRTX https://t.co/7q3JhJZ4LH May 8th 2021, 3:05pm |
 |
@intratio $MRTX https://t.co/atIwywbwbY Mirati Therapeutics Inc The AI is forecasting that this stock price will fall in the… https://t.co/kw9oc1NwNw May 8th 2021, 11:05am |
 |
@DickMedChem @Biotech2k1 $MRTX Aren’t you concerned by efficacy that seems to be only similar to $AMGN sotorasib while tox is worse? May 7th 2021, 10:05pm |
 |
@Tickeron $MRTX in Downtrend: 50-day Moving Average moved below 200-day Moving Average on April 22, 2021. View odds for this… https://t.co/JupHRomgyc May 7th 2021, 10:05pm |
 |
@Orangeman1992 @The_Ravid $MRTX and $CCXI dampen the mood May 7th 2021, 5:05pm |
 |
@YuZhu4 RT @biotechinvstr: Why is $MRTX thinking about “sequential” combo with PD-1? And what does it mean for the first line opportunity? Also tal… May 7th 2021, 5:05pm |
 |
@monaco_biotech Note to myself: Don‘t touch this ? $MRTX https://t.co/FvjZPzYUzf May 7th 2021, 4:05pm |
|
@QuantchaIdeas Big Loser Alert: Trading today’s -10.1% move in MIRATI THERAPEUTICS INC. COMM $MRTX https://t.co/e1fwNFQZLs May 7th 2021, 3:05pm |
 |
@MarcJacksonLA $MRTX JonesTrading Maintains Buy Rating On Mirati Therapeutics, $300 PT https://t.co/pQTZr1as3B May 7th 2021, 2:05pm |
 |
@hongdrew RT @biotechinvstr: $MRTX -8% early doors https://t.co/QSgAoRi4sU May 7th 2021, 2:05pm |
 |
@adamfeuerstein And $MRTX down low-double digits since April 27, when $AMGN update on its own KRAS drug raised a bunch of questions… https://t.co/ffrAffcPV3 May 7th 2021, 2:05pm |
 |
@ScripMandy RT @bio_clouseau: $MRTX guided to filing an ind for its KRAS G12D in 1H21 last year. Now sometime in 2022 May 7th 2021, 2:05pm |
 |
@bio_clouseau $MRTX guided to filing an ind for its KRAS G12D in 1H21 last year. Now sometime in 2022 May 7th 2021, 2:05pm |
 |
@biotechinvstr $MRTX -8% early doors https://t.co/QSgAoRi4sU May 7th 2021, 1:05pm |
 |
@Biohazard3737 $MRTX -8% is probably adding to the pain for a lot of funds. May 7th 2021, 1:05pm |
|
@biotechinvstr Why is $MRTX thinking about “sequential” combo with PD-1? And what does it mean for the first line opportunity? Als… https://t.co/UXE3sOS4Eg May 7th 2021, 11:05am |
 |
@newsfilterio Mirati Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Updates $MRTX https://t.co/UXplEOhPlC May 7th 2021, 7:05am |
 |
@Briefingcom $MRTX: Mirati Therapeutics misses by $0.53, misses on revs https://t.co/vS8qW06WYt May 6th 2021, 11:05pm |
|
@newsfilterio Mirati Therapeutics EPS misses by $0.54 $MRTX https://t.co/6m6ZbYl40C May 6th 2021, 11:05pm |
|
@MarcJacksonLA $MRTX Mirati Therapeutics Reports 1Q 2021 Results and Corporate Update https://t.co/flgPedbUUx May 6th 2021, 9:05pm |
 |
@EdgarInsider A Form 8-K [Press/News Current Report] filing has been made with the SEC: $MRTX #MiratiTherapeutics, Inc.… https://t.co/K672paInTY May 6th 2021, 8:05pm |
|
@EdgarInsider SEC Form 10-Q [Quarterly Report] filed by $MRTX #MiratiTherapeutics, Inc. #MiratiTherapeutics, Inc https://t.co/iAShktU72P May 6th 2021, 8:05pm |
 |
@otcdynamics $MRTX Mirati Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Updates https://t.co/B7KKREqR6T May 6th 2021, 8:05pm |
|
@biotechinvstr RT @MSollender: $MRTX Plan to file an Investigational New Drug (IND) application in 2022 for our investigational KRASG12D inhibitor, MRTX11… May 6th 2021, 8:05pm |
 |
@MSollender $MRTX Plan to file an Investigational New Drug (IND) application in 2022 for our investigational KRASG12D inhibitor… https://t.co/oVe2MKxeYL May 6th 2021, 8:05pm |
 |
@maxm_profit RT @Tickeron: Mirati Therapeutics Inc to report earnings on August 05, 2021. Earnings per share (EPS) estimate: $-2.20 $MRTX #MiratiTherape… May 6th 2021, 10:05am |
|
@Tickeron Mirati Therapeutics Inc to report earnings on August 05, 2021. Earnings per share (EPS) estimate: $-2.20 $MRTX… https://t.co/QvYXUfuYOD May 6th 2021, 2:05am |
 |
@Biotech2k1 Added some $MRTX today to bring up my position to 2.75%. This is part of my play to build bigger positions in the l… https://t.co/qYcVsPCoW5 May 3rd 2021, 1:05pm |
 |
@Gambiste1 RT @adamfeuerstein: $AMGN KRAS cancer drug had a bad week, but worry about pricing, not safety -- with implications for $MRTX as well http… May 3rd 2021, 12:05pm |
|
@adamfeuerstein $AMGN KRAS cancer drug had a bad week, but worry about pricing, not safety -- with implications for $MRTX as well https://t.co/Qo5IFE7j4l May 3rd 2021, 11:05am |
|
@Tickeron $MRTX in +3.62% Uptrend, rising for three consecutive days on April 30, 2021. View odds for this and other indicato… https://t.co/RHpqZxHwwc May 3rd 2021, 7:05am |
|
@Tickeron $MRTX in +3.62% Uptrend, rising for three consecutive days on April 30, 2021. View odds for this and other indicato… https://t.co/KaTACr4gg4 May 2nd 2021, 1:05pm |
 |
@falling_knife_ $MRTX #Earnings 5/5 Looking like a reversal on the weekly. I bet it hits 180 this week. https://t.co/ouDLoAOkrW May 1st 2021, 8:05pm |
 |
@Alan_PMor RT @Tickeron: $MRTX in +7.55% Uptrend, advancing for three consecutive days on April 29, 2021. View odds for this and other indicators: htt… May 1st 2021, 3:05pm |
|
@Tickeron $MRTX in +7.55% Uptrend, advancing for three consecutive days on April 29, 2021. View odds for this and other indic… https://t.co/909qdrYUPx May 1st 2021, 3:05pm |
|
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in MIRATI THERAPEUTICS INC. COMM $MRTX https://t.co/LNV4ni9ZiY May 1st 2021, 1:05pm |
 |
@optstrader1 RT @PMDiChristina: $MRTX nice spot to take a position. https://t.co/5fx3AXLIDP April 30th 2021, 1:04pm |
|
@optstrader1 RT @SeekingAlpha: $MRTX - Mirati Therapeutics: Another Growth Cycle Approaching. https://t.co/QLNJ1v04AI #trading #economy #business April 30th 2021, 1:04pm |
|
@optstrader1 RT @bearcapital1: $RVMD what a disappointment. $MRTX looks better than ever April 30th 2021, 1:04pm |
 |
@bearcapital1 $RVMD what a disappointment. $MRTX looks better than ever April 30th 2021, 11:04am |
 |
@StckPro $BGNE $MRTX NEW ARTICLE : Mirati Therapeutics: Another Growth Cycle Approaching https://t.co/EAk5zzKhFP Get all the… https://t.co/FPWFIQDq4A April 30th 2021, 10:04am |
 |
@SeekingAlpha $MRTX - Mirati Therapeutics: Another Growth Cycle Approaching. https://t.co/QLNJ1v04AI #trading #economy #business April 30th 2021, 10:04am |
 |
@PMDiChristina $MRTX nice spot to take a position. https://t.co/5fx3AXLIDP April 30th 2021, 4:04am |
 |
@Jarvis_Alerts $MRTX 165C Exp:21-May-21 ?? ? Total(Day): $460,000 #SmartMoneyFlow https://t.co/HkSFacojbI April 28th 2021, 10:04pm |
 |
@TradeWithAlerts Nice Print for $MRTX - Amount: $36,424,323.52 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt! April 28th 2021, 9:04pm |
 |
@evaluatevantage Amgen’s low-dose Kras curveball (Via @JacobPlieth) #sotorasib #Lumakras $AMGN $MRTX #adagrasib #FDA https://t.co/nVKoU0VIYC April 28th 2021, 3:04pm |
 |
@bearcapital1 $BDTX reminds me in a way of $mrtx April 28th 2021, 12:04pm |
 |
@mediasentiment $MRTX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 103 April 28th 2021, 9:04am |
|
@Tickeron $MRTX in +4.11% Uptrend, growing for three consecutive days on April 21, 2021. View odds for this and other indicat… https://t.co/RRYitQNCGv April 28th 2021, 9:04am |
|
@bearcapital1 @biotechinvstr Pre clinical data presented on September 18th and at J.P Morgan showed 10/10 regression vs 7/10 for $mrtx April 27th 2021, 4:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
